
|Videos|September 30, 2021
Rezum as a new option for treating large prostate patients with BPH
Author(s)Urology Times staff
“[Rezum] does give men another option, and so I think that's…really what we're focusing on here: giving the option to avoid general anesthesia and to avoid a bigger surgery,” says Michael A. Palese, MD.
Advertisement
In this video, Michael A. Palese, MD, and Evan Garden discuss the background and findings of the study, “Rezum for men with large prostates ≥80 cc versus small prostates <80 cc: Updates outcomes and long-term results,” presented recently at the 2021 American Urological Association Annual Meeting. Dr. Palese is the Chair of the Department of Urology at Mount Sinai Downtown & Beth Israel Medical Center and Evan Garden is a fourth-year medical student at the Icahn School of Medicine at Mount Sinai, New York, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










